A. Gregorakis

发表

Immunohistochemical Expression of Bcl 2 is an Independent Predictor of Time-to-biochemical Failure in Patients with Clinically Localized Prostate Cancer Following Radical Prostatectomy

A. Scorilas, K. Revelos, C. Petraki, 2009 .

Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy.

A. Scorilas, K. Revelos, C. Petraki, 2005, Anticancer research.

p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.

Andreas Scorilas, Michael Koutsilieris, Kyriakos Revelos, 2005, In vivo.

L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma.

A. Scorilas, C. Petraki, A. Gregorakis, 2015, Clinical biochemistry.

Prostate-specific membrane antigen: current and future utility.

G. Murphy, A. Gregorakis, E. Holmes, 1998, Seminars in urologic oncology.

Evaluation of routine application of P504S, 34βE12 and p63 immunostaining on 250 prostate needle biopsy specimens

A. Gregorakis, K. Pavlakis, C. Constantinides, 2010, International Urology and Nephrology.

Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma.

I. Gkialas, A. Gregorakis, M. Lykourinas, 2008, Urology.

Clinical evaluation of microRNA-145 expression in renal cell carcinoma: a promising molecular marker for discriminating and staging the clear cell histological subtype

Andreas Scorilas, A. Scorilas, C. Petraki, 2016, Biological chemistry.

Prognostic Implications of the Immunohistochemical Expression of Human Kallikreins 5, 6, 10 and 11 in Renal Cell Carcinoma

G. Yousef, E. Diamandis, M. Levesque, 2005, Tumor Biology.

Delayed reaction to the Dacron buttress used in Stamey bladder neck suspension

G. Rallis, A. Gregorakis, I. Kastriotis, 2005, International Urology and Nephrology.

Comparison of serum PSMA, PSA levels with results of cytogen‐356 ProstaScint® scanning in prostatic cancer patients

A. Partin, W. Nelp, H. Ragde, 1997, The Prostate.

Prostate cancer with small-cell morphology: An immunophenotypic subdivision

K. Revelos, C. Petraki, A. Gregorakis, 2005, Scandinavian journal of urology and nephrology.

Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues

C. Petraki, A. Gregorakis, P. Papanastasiou, 2003, Prostate Cancer and Prostatic Diseases.

p 27 kip 1 and Ki-67 ( MIB 1 ) Immunohistochemical Expression in Radical Prostatectomy Specimens of Patients with Clinically Localized Prostate Cancer

A. Scorilas, K. Revelos, C. Petraki, 2009 .

L-DOPA decarboxylase mRNA levels provide high diagnostic accuracy and discrimination between clear cell and non-clear cell subtypes in renal cell carcinoma.

A. Scorilas, C. Petraki, A. Gregorakis, 2015, Clinical biochemistry.